B&G FOODS INC (BGS) Fundamental Analysis & Valuation

NYSE:BGS • US05508R1068

Current stock price

5.54 USD
0 (0%)
At close:
5.58 USD
+0.04 (+0.72%)
After Hours:

This BGS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BGS Profitability Analysis

1.1 Basic Checks

  • BGS had positive earnings in the past year.
  • In the past year BGS had a positive cash flow from operations.
  • BGS had negative earnings in 4 of the past 5 years.
  • BGS had a positive operating cash flow in each of the past 5 years.
BGS Yearly Net Income VS EBIT VS OCF VS FCFBGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • With a Return On Assets value of -1.53%, BGS is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
  • The Return On Equity of BGS (-9.55%) is worse than 62.07% of its industry peers.
  • BGS has a better Return On Invested Capital (5.55%) than 62.07% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BGS is in line with the industry average of 7.69%.
Industry RankSector Rank
ROA -1.53%
ROE -9.55%
ROIC 5.55%
ROA(3y)-3.94%
ROA(5y)-2.07%
ROE(3y)-21.78%
ROE(5y)-11.87%
ROIC(3y)5.85%
ROIC(5y)5.35%
BGS Yearly ROA, ROE, ROICBGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • With a decent Operating Margin value of 10.04%, BGS is doing good in the industry, outperforming 75.86% of the companies in the same industry.
  • BGS's Operating Margin has declined in the last couple of years.
  • BGS has a Gross Margin of 21.81%. This is comparable to the rest of the industry: BGS outperforms 54.02% of its industry peers.
  • In the last couple of years the Gross Margin of BGS has declined.
Industry RankSector Rank
OM 10.04%
PM (TTM) N/A
GM 21.81%
OM growth 3Y3.14%
OM growth 5Y-6.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.82%
GM growth 5Y-2.28%
BGS Yearly Profit, Operating, Gross MarginsBGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

3

2. BGS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BGS is destroying value.
  • BGS has more shares outstanding than it did 1 year ago.
  • BGS has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BGS is higher compared to a year ago.
BGS Yearly Shares OutstandingBGS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
BGS Yearly Total Debt VS Total AssetsBGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • BGS has an Altman-Z score of 1.41. This is a bad value and indicates that BGS is not financially healthy and even has some risk of bankruptcy.
  • BGS's Altman-Z score of 1.41 is on the low side compared to the rest of the industry. BGS is outperformed by 65.52% of its industry peers.
  • BGS has a debt to FCF ratio of 27.56. This is a negative value and a sign of low solvency as BGS would need 27.56 years to pay back of all of its debts.
  • BGS has a Debt to FCF ratio (27.56) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 4.30 is on the high side and indicates that BGS has dependencies on debt financing.
  • BGS's Debt to Equity ratio of 4.30 is on the low side compared to the rest of the industry. BGS is outperformed by 83.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.3
Debt/FCF 27.56
Altman-Z 1.41
ROIC/WACC0.71
WACC7.78%
BGS Yearly LT Debt VS Equity VS FCFBGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • BGS has a Current Ratio of 3.32. This indicates that BGS is financially healthy and has no problem in meeting its short term obligations.
  • BGS's Current ratio of 3.32 is amongst the best of the industry. BGS outperforms 83.91% of its industry peers.
  • BGS has a Quick Ratio of 1.43. This is a normal value and indicates that BGS is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.43, BGS is doing good in the industry, outperforming 70.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 1.43
BGS Yearly Current Assets VS Current LiabilitesBGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2

3. BGS Growth Analysis

3.1 Past

  • The earnings per share for BGS have decreased strongly by -27.14% in the last year.
  • The earnings per share for BGS have been decreasing by -25.75% on average. This is quite bad
  • BGS shows a decrease in Revenue. In the last year, the revenue decreased by -5.37%.
  • Measured over the past years, BGS shows a decrease in Revenue. The Revenue has been decreasing by -1.46% on average per year.
EPS 1Y (TTM)-27.14%
EPS 3Y-23.07%
EPS 5Y-25.75%
EPS Q2Q%-9.68%
Revenue 1Y (TTM)-5.37%
Revenue growth 3Y-5.44%
Revenue growth 5Y-1.46%
Sales Q2Q%-2.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.37% on average over the next years. This is quite good.
  • Based on estimates for the next years, BGS will show a decrease in Revenue. The Revenue will decrease by -1.56% on average per year.
EPS Next Y21.32%
EPS Next 2Y14.52%
EPS Next 3Y17.37%
EPS Next 5YN/A
Revenue Next Year-6.45%
Revenue Next 2Y-3.03%
Revenue Next 3Y-1.56%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BGS Yearly Revenue VS EstimatesBGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
BGS Yearly EPS VS EstimatesBGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

8

4. BGS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.86 indicates a reasonable valuation of BGS.
  • Compared to the rest of the industry, the Price/Earnings ratio of BGS indicates a somewhat cheap valuation: BGS is cheaper than 77.01% of the companies listed in the same industry.
  • BGS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.77.
  • With a Price/Forward Earnings ratio of 8.95, the valuation of BGS can be described as very reasonable.
  • 94.25% of the companies in the same industry are more expensive than BGS, based on the Price/Forward Earnings ratio.
  • BGS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.75.
Industry RankSector Rank
PE 10.86
Fwd PE 8.95
BGS Price Earnings VS Forward Price EarningsBGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BGS indicates a somewhat cheap valuation: BGS is cheaper than 62.07% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BGS is valued cheaper than 86.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.3
EV/EBITDA 9.36
BGS Per share dataBGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BGS's earnings are expected to grow with 17.37% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y14.52%
EPS Next 3Y17.37%

5

5. BGS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 14.42%, BGS is a good candidate for dividend investing.
  • BGS's Dividend Yield is rather good when compared to the industry average which is at 2.24. BGS pays more dividend than 100.00% of the companies in the same industry.
  • BGS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 14.42%

5.2 History

  • The dividend of BGS decreases each year by -16.37%.
  • BGS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • BGS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-16.37%
Div Incr Years0
Div Non Decr Years2
BGS Yearly Dividends per shareBGS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • BGS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-140.09%
EPS Next 2Y14.52%
EPS Next 3Y17.37%
BGS Yearly Income VS Free CF VS DividendBGS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

BGS Fundamentals: All Metrics, Ratios and Statistics

B&G FOODS INC

NYSE:BGS (5/1/2026, 5:05:00 PM)

After market: 5.58 +0.04 (+0.72%)

5.54

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Industry Strength23.6
Industry Growth11.18
Earnings (Last)03-03
Earnings (Next)05-13
Inst Owners64.34%
Inst Owner Change-0.32%
Ins Owners4.67%
Ins Owner Change13.06%
Market Cap445.47M
Revenue(TTM)1.83B
Net Income(TTM)-43.26M
Analysts48.33
Price Target5.1 (-7.94%)
Short Float %14.31%
Short Ratio5.04
Dividend
Industry RankSector Rank
Dividend Yield 14.42%
Yearly Dividend0.76
Dividend Growth(5Y)-16.37%
DP-140.09%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.98%
Min EPS beat(2)-7.59%
Max EPS beat(2)33.56%
EPS beat(4)1
Avg EPS beat(4)-20.26%
Min EPS beat(4)-74.14%
Max EPS beat(4)33.56%
EPS beat(8)2
Avg EPS beat(8)-18.59%
EPS beat(12)6
Avg EPS beat(12)-5.61%
EPS beat(16)7
Avg EPS beat(16)-4.6%
Revenue beat(2)0
Avg Revenue beat(2)-0.35%
Min Revenue beat(2)-0.45%
Max Revenue beat(2)-0.25%
Revenue beat(4)0
Avg Revenue beat(4)-2.73%
Min Revenue beat(4)-8.34%
Max Revenue beat(4)-0.25%
Revenue beat(8)1
Avg Revenue beat(8)-1.99%
Revenue beat(12)2
Avg Revenue beat(12)-1.78%
Revenue beat(16)4
Avg Revenue beat(16)-1.02%
PT rev (1m)9.09%
PT rev (3m)11.11%
EPS NQ rev (1m)-11.15%
EPS NQ rev (3m)-13.52%
EPS NY rev (1m)22.18%
EPS NY rev (3m)22.18%
Revenue NQ rev (1m)-0.22%
Revenue NQ rev (3m)-2.64%
Revenue NY rev (1m)2.56%
Revenue NY rev (3m)-4.85%
Valuation
Industry RankSector Rank
PE 10.86
Fwd PE 8.95
P/S 0.24
P/FCF 6.3
P/OCF 4.39
P/B 0.98
P/tB N/A
EV/EBITDA 9.36
EPS(TTM)0.51
EY9.21%
EPS(NY)0.62
Fwd EY11.17%
FCF(TTM)0.88
FCFY15.88%
OCF(TTM)1.26
OCFY22.76%
SpS22.74
BVpS5.63
TBVpS-15.94
PEG (NY)0.51
PEG (5Y)N/A
Graham Number8.0396 (45.12%)
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -9.55%
ROCE 7.03%
ROIC 5.55%
ROICexc 5.67%
ROICexgc 17.67%
OM 10.04%
PM (TTM) N/A
GM 21.81%
FCFM 3.87%
ROA(3y)-3.94%
ROA(5y)-2.07%
ROE(3y)-21.78%
ROE(5y)-11.87%
ROIC(3y)5.85%
ROIC(5y)5.35%
ROICexc(3y)5.96%
ROICexc(5y)5.44%
ROICexgc(3y)19.22%
ROICexgc(5y)17.87%
ROCE(3y)7.41%
ROCE(5y)6.78%
ROICexgc growth 3Y8.08%
ROICexgc growth 5Y-7.13%
ROICexc growth 3Y8.56%
ROICexc growth 5Y-2.05%
OM growth 3Y3.14%
OM growth 5Y-6.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.82%
GM growth 5Y-2.28%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 4.3
Debt/FCF 27.56
Debt/EBITDA 7.79
Cap/Depr 46.28%
Cap/Sales 1.68%
Interest Coverage 1.23
Cash Conversion 40.59%
Profit Quality N/A
Current Ratio 3.32
Quick Ratio 1.43
Altman-Z 1.41
F-Score4
WACC7.78%
ROIC/WACC0.71
Cap/Depr(3y)41.18%
Cap/Depr(5y)40.76%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.14%
EPS 3Y-23.07%
EPS 5Y-25.75%
EPS Q2Q%-9.68%
EPS Next Y21.32%
EPS Next 2Y14.52%
EPS Next 3Y17.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.37%
Revenue growth 3Y-5.44%
Revenue growth 5Y-1.46%
Sales Q2Q%-2.17%
Revenue Next Year-6.45%
Revenue Next 2Y-3.03%
Revenue Next 3Y-1.56%
Revenue Next 5YN/A
EBIT growth 1Y-13.81%
EBIT growth 3Y-2.47%
EBIT growth 5Y-7.86%
EBIT Next Year34.94%
EBIT Next 3Y12.63%
EBIT Next 5YN/A
FCF growth 1Y-31.46%
FCF growth 3YN/A
FCF growth 5Y-22.61%
OCF growth 1Y-22.55%
OCF growth 3Y156.62%
OCF growth 5Y-18.47%

B&G FOODS INC / BGS Fundamental Analysis FAQ

What is the fundamental rating for BGS stock?

ChartMill assigns a fundamental rating of 4 / 10 to BGS.


What is the valuation status for BGS stock?

ChartMill assigns a valuation rating of 8 / 10 to B&G FOODS INC (BGS). This can be considered as Undervalued.


How profitable is B&G FOODS INC (BGS) stock?

B&G FOODS INC (BGS) has a profitability rating of 3 / 10.


What are the PE and PB ratios of B&G FOODS INC (BGS) stock?

The Price/Earnings (PE) ratio for B&G FOODS INC (BGS) is 10.86 and the Price/Book (PB) ratio is 0.98.


Can you provide the expected EPS growth for BGS stock?

The Earnings per Share (EPS) of B&G FOODS INC (BGS) is expected to grow by 21.32% in the next year.